^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
SHR-1501
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Jiangsu Hengrui Pharma
Drug class:
IL-15R agonist
Related drugs:
Phase 1
Jiangsu HengRui Medicine Co., Ltd.
Completed
Last update posted :
09/27/2023
Initiation :
02/14/2020
Primary completion :
01/12/2023
Completion :
01/12/2023
CD8
|
Ariely (adebrelimab) • SHR-1501
Share
